Unlock instant, AI-driven research and patent intelligence for your innovation.

Levorotatory meptazinol derivative, preparation method and pharmaceutical application thereof

A pharmacy and compound technology, applied in the directions of drug combination, active ingredients of heterocyclic compounds, organic chemistry, etc., can solve the problems of weakened curative effect, cure the symptoms but not the root cause, etc., and achieve the effect of high therapeutic index and small toxic and side effects.

Active Publication Date: 2012-12-12
上海市生物医药技术研究院
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] However, the above-mentioned acetylcholinesterase inhibitors only increase its concentration by reducing the destruction of acetylcholine, and "treat the symptoms but not the root cause" during the treatment process, and because the number of neurons that can release acetylcholine will decrease with the progress of the disease, so the symptoms can be improved The efficacy will also be weakened

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Levorotatory meptazinol derivative, preparation method and pharmaceutical application thereof
  • Levorotatory meptazinol derivative, preparation method and pharmaceutical application thereof
  • Levorotatory meptazinol derivative, preparation method and pharmaceutical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] Example 1 N-[2-(1H-indol-3-yl)ethyl]-8-bromooctylamide

[0073] 0.22 g (1.0 mmol) of 8-bromooctanoic acid was dissolved in 20 mL of anhydrous CH 2 C1 2 Add EDC 0.19g (1.0mmol), DMAP 0.12g (1.0mmol), stir evenly, add tryptamine 0.16g (1.0mmol), stir and react at room temperature for 2 hours, a white solid precipitates, filter, add 1N to the filtrate Wash with 10 mL of hydrochloric acid, then with 10 mL of water, and wash with anhydrous Na 2 SO 4 dry. Filtration, concentration, silica gel column chromatography (CH 2 C1 2 ~5%EtOH / CH 2 C1 2 ) to obtain brown oily substance 0.25g, yield 68.4%.

[0074] 1 HNMR (CDCl 3 ): 8.30 (s, 1H, NH, heavy water exchange disappears), 7.61 (d, J = 8Hz, 1H, ArH), 7.39 (d, J = 8Hz, 1H, ArH), 7.21 (t, J = 7Hz, 1H , ArH), 7.13(t, J=7Hz, 1H, ArH), 7.03(s, 1H, ArH), 5.56(s, 1H, NHCO, heavy water exchange disappeared), 3.61(dd, J=6.1Hz, 2H, N-CH 2 ), 3.39 (t, J=6.7Hz, 2H, BrCH 2 ), 2.98(t, J=6.5Hz, 2H, indoL-CH 2 ), 2.09(t, J=7Hz, ...

Embodiment 7

[0079] Example 7 5-[(1′,2′-dithiolane)-3-yl]-N-(3-chloropropyl)-pentanamide

[0080]Dissolve 0.65 g (5.00 mmol) of 3-chloropropylamine hydrochloride in 30 mL of anhydrous CH 2 C1 2 Add EDC 1.2g (6.26mmol), DMAP 2.0g (16.3mmol), stir well, add lipoic acid 1.05g (5.09mmol), vacuumize, fill with nitrogen three times, under nitrogen protection, stir at room temperature for 12-24 hours, washed with 10 mL of 1N hydrochloric acid, washed twice with 10 mL of water, and washed with anhydrous Na 2 SO 4 dry. Filter and concentrate to obtain 0.99 g of a grass-green oil. Silica gel column chromatography (eluent: ethyl acetate) gave 360.51 g of a light yellow oily substance, with a yield of 36.2%.

[0081] 1 HNMR (CDCl 3 ): 6.01(s, 1H, NHCO, heavy water exchange disappears), 3.55(t, J=6.3Hz, 2H, CL-CH 2 ), 3.54-3.52 (m, 1H, S-CH 2 ), 3.37 (dd, J 1 =12.7Hz,J 2 =6.3Hz, 2H, N-CH 2 ), 3.18-3.05 (m, 2H, S-CH 2 ), 2.47-2.39 (m, 1H, SCH 2 CH 2 ), 2.16(t, J=7.4Hz, 2H, CH 2 CO), 2.00...

Embodiment 8

[0083] Example 8 6-[(S)-3-Ethyl-3-(3′-hydroxyphenyl)-azepan-1-yl]-N-[2-(1H-indole-3- base) ethyl]-hexanamide

[0084] (3S)-N-Desmethylmaprotamol 0.35g (1.60mmol) was slightly heated and dissolved in 10mL of acetonitrile, and triethylamine 0.3mL (2.15mmol) was added. 0.61 g (1.81 mmol) of the compound of Example 2 was added under stirring, refluxed for 4 hours, cooled to room temperature, concentrated to dryness, added 10 mL of saturated sodium carbonate solution, and extracted with 15 mL×4 of chloroform. The organic layers were combined and dried over anhydrous sodium sulfate. Filtration and concentration to dryness gave 0.78g yellow oil, which was subjected to silica gel column chromatography (8%, 20% EtOH / CHCl 3 ) to obtain a nearly colorless oily substance, a small amount of EA was added, and 0.49 g of a white solid was precipitated, with a yield of 64.5%, mp.82-85°C.

[0085] 1 HNMR (CDCl 3 ): 8.85 (s, 1H, NH, heavy water exchange disappears), 7.55 (d, J = 7.8Hz, 1H, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Yieldaaaaaaaaaa
Login to View More

Abstract

The invention discloses relates to levorotatory meptazinol derivative and / or pharmaceutically acceptable salt represented by general formula (I) or (II). The definition of each perssad in the formulas is shown in the specification. The invention further relates to a preparation method of the compound, and pharmacy applications thereof for treating diseases like Alzheimer's disease. Functions of acetylcholine esterase inhibition, beta amyloid (A Beta) aggregation resistance and antioxidant activity are simultaneously displayed in the compound which can be taken as multipurpose medicine for treating alzheimer's disease.

Description

technical field [0001] The present invention relates to the field of pharmacy, in particular to a new class of levomaprotamol derivatives with bifunctional groups or pharmaceutically acceptable salts thereof, and the present invention also relates to a preparation method of said levomaprotamol derivatives, The present invention further relates to the pharmaceutical use of the levomaprotamol derivative. Background technique [0002] Alzheimer's Disease (AD), also known as Alzheimer's disease, is a chronic progressive central nervous system degenerative disease. At present, there are more than 50 million elderly people in the world suffering from different degrees of senile dementia. With the advent of "population aging society", the number of AD patients will increase sharply. It is estimated that by 2050, the number of dementia patients in the world will increase More than 100 million, the market demand for AD therapeutic drugs is huge, and its research has become a hot spo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D403/12C07D409/12A61K31/55A61P25/28A61P25/16
Inventor 郑伟仇缀百陈海林陈建兴陈良康余丽宁黄婷
Owner 上海市生物医药技术研究院